Inc. (CARA), a biopharmaceutical company focused on pruritus treatments, has announced the effective date of a 1-for-12 reverse stock split. Cara's common stock begined trading on a reverse stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback